EPO mRNA Expression in Fetal and Newborn Liver, Kidney, Spleen, and Bone Marrow Tissue
| . | Liver . | Kidney . | Spleen . | Bone Marrow . |
|---|---|---|---|---|
| EPO mRNA positive samples | 64 of 66 | 55 of 59 | 61 of 64 | 17 of 21 |
| No./% | 97% | 93% | 95% | 81% |
| Weight (g) | 25.25 | 2.40 | 0.70 | Not possible |
| (3.90-421.50) | (0.30-30.50) | (0.07-86.00) | ||
| Total RNA (μg/g) | 2,274 | 1,043 | 1,200 | 523 |
| (615-4,243) | (71-6,045) | (75-3,433) | (143-2,160) | |
| EPO mRNA (amol/μg total RNA) | 3.64 | 0.70 | 0.46 | 0.93 |
| (0.03-218.00) | (0.12-731.00) | (0.03-15.00) | (0.12-7.30) | |
| EPO mRNA (amol/g) | 7,997 | 686 | 460 | 485 |
| (234-605,893) | (14-1,305,000) | (5-19,057) | (17-2,757) | |
| Total EPO mRNA (amol/organ) | 155,013 | 1,462 | 363 | Not possible |
| (475-138,325,339) | (10-23,490,000) | (10-30,213) |
| . | Liver . | Kidney . | Spleen . | Bone Marrow . |
|---|---|---|---|---|
| EPO mRNA positive samples | 64 of 66 | 55 of 59 | 61 of 64 | 17 of 21 |
| No./% | 97% | 93% | 95% | 81% |
| Weight (g) | 25.25 | 2.40 | 0.70 | Not possible |
| (3.90-421.50) | (0.30-30.50) | (0.07-86.00) | ||
| Total RNA (μg/g) | 2,274 | 1,043 | 1,200 | 523 |
| (615-4,243) | (71-6,045) | (75-3,433) | (143-2,160) | |
| EPO mRNA (amol/μg total RNA) | 3.64 | 0.70 | 0.46 | 0.93 |
| (0.03-218.00) | (0.12-731.00) | (0.03-15.00) | (0.12-7.30) | |
| EPO mRNA (amol/g) | 7,997 | 686 | 460 | 485 |
| (234-605,893) | (14-1,305,000) | (5-19,057) | (17-2,757) | |
| Total EPO mRNA (amol/organ) | 155,013 | 1,462 | 363 | Not possible |
| (475-138,325,339) | (10-23,490,000) | (10-30,213) |
(Median and range).